The success of this project may enable the development of actionable, personalised interventional strategies to slow down ageing and prevent/delay age-predisposed diseases.
The aims of the ALLTogether study are to improve survival and quality of survival for children and young adults with ALL. ALL in young people has excellent outcome with >90% survival in children and about 75% in young adults. However, patients still die of diseases after relapse as a result of under-treatment.
Cancer in children is rare. But cancer remains the disease causing the most deaths in children over the age of 1 year. Most children, who die from cancer, do so because the standard treatment doesn't make their disease disappear (resistant disease) or because the disease returns (relapse of the disease). These children are at a high risk of dying from their cancer and we need to develop new treatments for them.
In a new report, researchers present six recommendations to optimise the use of the concept of ‘Nordic added value’ across Nordic institutions. The recommendations focus on creating greater cohesion, promoting long-term value and strengthening Nordic identity.
When we work together and cooperate across borders in the Nordic countries, we become stronger and can achieve more. This is what we call Nordic added value.
The proposed university cooperation initiative, Nordic University Cooperation on Edge Intelligence (NUEI), focuses on edge intelligence, a Nordic area of growth and a key technology enabler in many industrial domains and sustainability. The current Nordic Edge intelligence research efforts are fragmented and are supported by local national instruments, lacking the necessary mass to become an international area of excellence.
